7Baggers

Glaukos Corporation
(NYSE:GKOS) 

GKOS stock logo

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outf...

Founded: 1998
Full Time Employees: 600
Sector: Healthcare
Industry: Medical Instruments & Supplies
Healthcare
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 
                                                
      net sales
    		150,571,000 143,121,000 133,537,000 124,120,000 106,664,000 105,499,000 96,670,000 95,690,000 85,622,000 82,365,000 78,048,000 80,399,000 73,899,000 71,227,000 71,269,000 72,685,000 67,681,000 73,240,000 74,710,000 78,093,000 67,968,000 73,234,000 64,831,000 31,558,000 55,336,000 65,849,000 58,509,000 58,600,000 54,026,000 54,076,000 43,908,000 43,161,000 40,133,000 41,650,000 40,412,000 41,285,000 35,907,000 33,172,000 29,577,000 28,556,000 23,092,000 20,276,000 19,004,000 17,754,000 
      yoy
    		41.16% 35.66% 38.14% 29.71% 24.58% 28.09% 23.86% 19.02% 15.86% 15.64% 9.51% 10.61% 9.19% -2.75% -4.61% -6.93% -0.42% 0.01% 15.24% 147.46% 22.83% 11.22% 10.81% -46.15% 2.42% 21.77% 33.25% 35.77% 34.62% 29.83% 8.65% 4.54% 11.77% 25.56% 36.63% 44.58% 55.50% 63.60% 55.64% 60.84%     
      qoq
    		5.21% 7.18% 7.59% 16.37% 1.10% 9.13% 1.02% 11.76% 3.95% 5.53% -2.92% 8.80% 3.75% -0.06% -1.95% 7.39% -7.59% -1.97% -4.33% 14.90% -7.19% 12.96% 105.43% -42.97% -15.97% 12.55% -0.16% 8.47% -0.09% 23.16% 1.73% 7.54% -3.64% 3.06% -2.11% 14.98% 8.24% 12.15% 3.58% 23.66% 13.89% 6.69% 7.04%  
      cost of sales
    		33,339,000 31,771,000 28,831,000 26,896,000 24,316,000 28,635,000 22,584,000 22,550,000 20,258,000 18,891,000 18,510,000 20,103,000 18,071,000 17,222,000 16,861,000 17,833,000 17,063,000 16,865,000 15,370,000 17,759,000 16,633,000 19,590,000 17,932,000 21,668,000 32,529,000 15,904,000 7,703,000 7,870,000 7,111,000 7,118,000 6,011,000 6,160,000 5,786,000 4,630,000 5,718,000 5,522,000 5,180,000 4,811,000 3,886,000 4,359,000 3,121,000 3,594,000 3,319,000 3,281,000 
      gross profit
    		117,232,000 -1,517,000 104,706,000 97,224,000 82,348,000 76,864,000 74,086,000 73,140,000 65,364,000 63,474,000 59,538,000 60,296,000 55,828,000 54,005,000 54,408,000 54,852,000 50,618,000 56,375,000 59,340,000 60,334,000 51,335,000 53,644,000 46,899,000 9,890,000 22,807,000 49,945,000 50,806,000 50,730,000 46,915,000 46,958,000 37,897,000 37,001,000 34,347,000 37,020,000 34,694,000 35,763,000 30,727,000 28,361,000 25,691,000 24,197,000 19,971,000 16,682,000 15,685,000 14,473,000 
      yoy
    		42.36% -101.97% 41.33% 32.93% 25.98% 21.10% 24.43% 21.30% 17.08% 17.53% 9.43% 9.92% 10.29% -4.20% -8.31% -9.09% -1.40% 5.09% 26.53% 510.05% 125.08% 7.41% -7.69% -80.50% -51.39% 6.36% 34.06% 37.10% 36.59% 26.84% 9.23% 3.46% 11.78% 30.53% 35.04% 47.80% 53.86% 70.01% 63.79% 67.19%     
      qoq
    		-7827.88% -101.45% 7.70% 18.06% 7.13% 3.75% 1.29% 11.90% 2.98% 6.61% -1.26% 8.00% 3.38% -0.74% -0.81% 8.36% -10.21% -5.00% -1.65% 17.53% -4.30% 14.38% 374.21% -56.64% -54.34% -1.69% 0.15% 8.13% -0.09% 23.91% 2.42% 7.73% -7.22% 6.70% -2.99% 16.39% 8.34% 10.39% 6.17% 21.16% 19.72% 6.36% 8.37%  
      gross margin %
    		77.86% -1.06% 78.41% 78.33% 77.20% 72.86% 76.64% 76.43% 76.34% 77.06% 76.28% 75.00% 75.55% 75.82% 76.34% 75.47% 74.79% 76.97% 79.43% 77.26% 75.53% 73.25% 72.34% 31.34% 41.22% 75.85% 86.83% 86.57% 86.84% 86.84% 86.31% 85.73% 85.58% 88.88% 85.85% 86.62% 85.57% 85.50% 86.86% 84.74% 86.48% 82.27% 82.54% 81.52% 
      operating expenses:
    		                                            
      selling, general and administrative
    		92,943,000 94,700,000 82,999,000 83,375,000 70,673,000 69,003,000 64,000,000 66,188,000 61,975,000 63,034,000 54,247,000 53,137,000 53,650,000 51,927,000 47,149,000 49,900,000 43,949,000 47,566,000 44,470,000 45,300,000 41,921,000 43,792,000 38,947,000 38,116,000 50,546,000 59,611,000 44,443,000 37,656,000 34,925,000 32,104,000 31,632,000 28,638,000 27,155,000 25,963,000 24,141,000 24,675,000 21,481,000 20,494,000 16,854,000 15,120,000 12,288,000 12,392,000 11,237,000 12,516,000 
      research and development
    		44,145,000 43,651,000 38,072,000 36,538,000 32,353,000 36,527,000 34,746,000 34,426,000 30,726,000 37,062,000 33,301,000 33,234,000 35,171,000 35,812,000 28,870,000 31,712,000 26,877,000 26,678,000 28,846,000 24,256,000 21,219,000 21,244,000 20,304,000 18,971,000 24,873,000 20,031,000 17,278,000 17,069,000 13,930,000 12,957,000 13,202,000 12,611,000 10,906,000 10,525,000 9,805,000 9,633,000 8,942,000 7,399,000 7,807,000 6,955,000 7,062,000 6,295,000 6,173,000 7,339,000 
      total operating expenses
    		137,088,000 138,351,000 121,071,000 119,913,000 103,026,000 105,530,000 98,746,000 103,114,000 104,430,000 102,096,000 87,548,000 89,371,000 88,821,000 87,739,000 76,019,000 91,612,000 40,826,000 74,244,000 48,316,000 74,556,000 63,140,000 65,036,000 59,251,000 57,087,000 75,419,000 79,642,000 63,221,000 56,970,000 48,855,000 45,061,000 44,834,000 41,249,000 38,061,000 36,488,000 33,946,000 39,628,000 30,423,000 27,893,000 24,661,000 22,075,000 19,350,000 18,687,000 17,410,000 19,855,000 
      income from operations
    		-19,856,000 -139,868,000 -16,365,000 -22,689,000 -20,678,000 -28,666,000 -24,660,000 -29,974,000 -39,066,000 -38,622,000 -28,010,000 -29,075,000 -32,993,000 -33,734,000 -21,611,000 -36,760,000 9,792,000 -17,869,000 11,024,000 -14,222,000 -11,805,000 -11,392,000 -12,352,000 -47,197,000 -52,612,000 -29,697,000 -12,415,000 -6,240,000 -1,940,000 1,897,000 -6,937,000 -4,248,000 -3,714,000 532,000 748,000 -3,865,000 304,000 468,000 1,030,000 2,122,000 621,000 -2,005,000 -1,725,000 -5,382,000 
      yoy
    		-3.98% 387.92% -33.64% -24.30% -47.07% -25.78% -11.96% 3.09% 18.41% 14.49% 29.61% -20.91% -436.94% 88.79% -296.04% 158.47% -182.95% 56.86% -189.25% -69.87% -77.56% -61.64% -0.51% 656.36% 2611.96% -1665.47% 78.97% 46.89% -47.77% 256.58% -1027.41% 9.91% -1321.71% 13.68% -27.38% -282.14% -51.05% -123.34% -159.71% -139.43%     
      qoq
    		-85.80% 754.68% -27.87% 9.73% -27.87% 16.24% -17.73% -23.27% 1.15% 37.89% -3.66% -11.88% -2.20% 56.10% -41.21% -475.41% -154.80% -262.09% -177.51% 20.47% 3.63% -7.77% -73.83% -10.29% 77.16% 139.20% 98.96% 221.65% -202.27% -127.35% 63.30% 14.38% -798.12% -28.88% -119.35% -1371.38% -35.04% -54.56% -51.46% 241.71% -130.97% 16.23% -67.95%  
      operating margin %
    		-13.19% -97.73% -12.26% -18.28% -19.39% -27.17% -25.51% -31.32% -45.63% -46.89% -35.89% -36.16% -44.65% -47.36% -30.32% -50.57% 14.47% -24.40% 14.76% -18.21% -17.37% -15.56% -19.05% -149.56% -95.08% -45.10% -21.22% -10.65% -3.59% 3.51% -15.80% -9.84% -9.25% 1.28% 1.85% -9.36% 0.85% 1.41% 3.48% 7.43% 2.69% -9.89% -9.08% -30.31% 
      non-operating income:
    		                                            
      interest income
    		2,431,000 2,512,000 2,552,000 2,574,000 3,076,000 2,494,000 2,700,000 2,828,000 3,083,000 2,912,000 2,710,000 1,894,000 1,648,000 960,000 744,000 384,000 287,000 272,000 291,000 342,000 383,000 498,000 595,000 590,000 696,000 801,000 780,000 800,000 788,000 684,000 583,000 505,000          72,000 10,000  
      interest expense
    		-1,125,000 -1,146,000 -1,175,000 -1,151,000 -1,163,000 -1,572,000 -1,663,000 -3,355,000 -3,450,000 -3,428,000 -3,398,000 -3,399,000 -3,408,000 -3,409,000 -3,481,000 -3,414,000 -3,416,000 -3,424,000 -3,413,000 -3,306,000 -3,229,000 -5,630,000 -5,732,000 -1,872,000 -881,000 -524,000 -1,028,000 -1,013,000                 
      other income
    		-749,000 -1,314,000 -1,009,000 1,857,000 945,000 -84,500 2,391,000  -1,028,000    528,000     -1,214,000 -1,470,000 -88,000  2,633,000 852,000 1,201,000    216,000 -68,000 -272,000 -230,000 -1,644,000             
      total non-operating income
    		557,000 52,000 368,000 3,280,000 2,858,000 -4,551,750 3,428,000                 -81,000 -1,896,000 437,000 -904,000 3,000 720,000 412,000 353,000 -1,139,000             
      loss before taxes
    		-19,299,000 -139,816,000 -15,997,000 -19,409,000 -17,820,000 -33,694,000 -21,232,000 -50,214,000 -40,461,000 -36,718,000 -30,407,000 -32,377,000    -45,641,000    -17,274,000 -16,190,000 -13,891,000 -16,637,000 -47,278,000 -54,508,000 -5,194,000 -13,319,000 -6,237,000 -1,220,000   -5,387,000          -2,257,000 -2,057,000 -32,512,000 
      income tax provision
    		484,000 -6,159,000 234,000 248,000 326,000 -114,000 177,000 331,000 377,000 61,000 37,000 435,000 401,000 298,000 247,000 -105,000 326,000 -363,000 202,000 208,000 279,000 -3,243,000 -889,000 -7,384,000 -450,000                    
      net income
    		-19,783,000 -133,657,000 -16,231,000 -19,657,000 -18,146,000 -33,580,000 -21,409,000 -50,545,000 -40,838,000 -36,779,000 -30,444,000 -32,812,000 -34,626,000 -31,460,000 -27,576,000 -45,536,000 5,377,000 -21,872,000 6,230,000 -17,482,000 -16,469,000 -10,648,000 -15,748,000 -39,894,000 -54,058,000 36,581,000 -13,506,000 -6,309,000 -1,342,000 1,779,000 -6,621,000 -5,398,000 -2,711,000 1,006,000 1,325,000 -3,301,000 878,000 134,000 1,159,000 2,332,000 897,000 -2,290,000 -2,057,000 -32,512,000 
      yoy
    		9.02% 298.03% -24.19% -61.11% -55.57% -8.70% -29.68% 54.04% 17.94% 16.91% 10.40% -27.94% -743.97% 43.84% -542.63% 160.47% -132.65% 105.41% -139.56% -56.18% -69.53% -129.11% 16.60% 532.33% 3928.17% 1956.27% 103.99% 16.88% -50.50% 76.84% -599.70% 63.53% -408.77% 650.75% 14.32% -241.55% -2.12% -105.85% -156.34% -107.17%     
      qoq
    		-85.20% 723.47% -17.43% 8.33% -45.96% 56.85% -57.64% 23.77% 11.04% 20.81% -7.22% -5.24% 10.06% 14.08% -39.44% -946.87% -124.58% -451.08% -135.64% 6.15% 54.67% -32.39% -60.53% -26.20% -247.78% -370.85% 114.08% 370.12% -175.44% -126.87% 22.66% 99.11% -369.48% -24.08% -140.14% -475.97% 555.22% -88.44% -50.30% 159.98% -139.17% 11.33% -93.67%  
      net income margin %
    		-13.14% -93.39% -12.15% -15.84% -17.01% -31.83% -22.15% -52.82% -47.70% -44.65% -39.01% -40.81% -46.86% -44.17% -38.69% -62.65% 7.94% -29.86% 8.34% -22.39% -24.23% -14.54% -24.29% -126.41% -97.69% 55.55% -23.08% -10.77% -2.48% 3.29% -15.08% -12.51% -6.76% 2.42% 3.28% -8.00% 2.45% 0.40% 3.92% 8.17% 3.88% -11.29% -10.82% -183.12% 
      basic and diluted net loss per share
    		-0.34 -2.33 -0.28 -0.34 -0.32 -0.59 -0.39 -1 -0.82 -0.75 -0.63 -0.68    -0.96    -0.38 -0.36 -0.62 -0.35 -0.9 -1.24 -0.145 -0.37                  
      weighted-average shares outstanding used to compute basic and diluted net loss per share
    		58,022 57,190 57,398 57,205 56,637 52,755    48,433    47,444                               
      acquired in-process research and development
    		       2,500,000 11,729,000 2,000,000  3,000,000                                 
      charges associated with convertible senior notes
    		       -18,012,000                                     
      weighted-average shares used for eps calculation
    		      55,037 50,715 49,580  48,675 48,281 47,881  47,614 47,356 47,050 46,423 46,737 46,306 45,709 44,497 44,706 44,335 43,766 37,355 36,831 36,470 36,205 35,317 35,541 34,942 34,677 34,381 34,472 34,322 34,146 32,928 33,116 32,652 32,317 17,474 32,006 2,912 
      non-operating expense:
    		                                            
      other expense
    		       -1,701,000  2,420,000 -1,709,000 -1,797,000  -2,448,000 -2,981,000 -5,851,000 -960,000    -1,539,000    -1,711,000 -127,000 -656,000                  
      total non-operating expense
    		       -20,240,000 -1,395,000 1,904,000 -2,397,000 -3,302,000 -1,232,000 2,572,000 -5,718,000 -8,881,000 -4,089,000 -3,007,250 -4,592,000 -3,052,000 -4,385,000 -1,565,500 -4,285,000                      
      litigation-related settlement
    		                -30,000,000  -30,000,000                          
      income before taxes
    		            -34,225,000 -16,816,750 -27,329,000  5,703,000 -6,758,000 6,432,000           2,309,000 -6,584,000  -2,706,000 -242,000 1,378,000 -3,279,000 933,000 1,132,000 1,299,000 2,332,000 897,000    
      basic and diluted net income per share
    		            -0.72 -0.358 -0.58                              
      in-process research and development
    		               10,000,000   5,000,000 5,000,000       1,500,000 2,245,000        5,320,000         
      basic net income per share
    		                0.11 -0.47 0.13           0.05 -0.19  -0.08 -0.008 0.04 -0.1 0.03        
      diluted net income per share
    		                0.11 -0.47 0.13           0.05 -0.19  -0.08 -0.008 0.04 -0.1 0.02        
      provision for income taxes
    		                         95,250 187,000 72,000 122,000 530,000 37,000 11,000 5,000 -37,000 53,000 22,000 55,000 -97,000 140,000      
      basic net loss per share
    		                           -0.17 -0.04   -0.15             
      diluted net loss per share
    		                           -0.17 -0.04   -0.15             
      other income, net:
    		                                            
      interest and other income
    		                                1,016,000 473,000 658,000 598,000 636,000 233,750 314,000 286,000 335,000    
      interest and other expense
    		                                 -11,750 -28,000 -12,000  -55,750 -45,000 -76,000 -102,000 -322,000 -178,000 -293,000 
      total other income
    		                                1,008,000 437,000 630,000 586,000 629,000 -431,000 269,000 210,000 276,000 -252,000 -332,000 -27,130,000 
      change in fair value of stock warrant liability
    		                                     10,750   43,000    
      loss on deconsolidation of dose
    		                                           -25,685,000 
      loss on extinguishment of debt
    		                                          -195,000  
      net loss attributable to noncontrolling interest
    		                                           -584,000 
      net income attributable to glaukos corporation
    		                                     134,000 1,159,000 2,332,000 897,000    
      basic net income per share attributable to glaukos corporation stockholders
    		                                     0.01 0.03 0.07 0.03    
      diluted net income per share attributable to glaukos corporation stockholders
    		                                      0.03 0.06 0.03    
      change in fair value of stock warrants
    		                                         -282,500 31,000 -1,152,000 
      net loss attributable to glaukos corporation
    		                                         -2,290,000 -2,057,000 -31,928,000 
      basic net loss per share attributable to glaukos corporation common stockholders
    		                                         -0.695 -0.06  
      diluted net loss per share attributable to glaukos corporation common stockholders
    		                                         -0.695 -0.07  
      net income per share
    		                                           -10.96 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 
                                                  
        assets
      		                                            
        current assets:
      		                                            
        cash and cash equivalents
      		104,249,000 90,813,000 98,246,000 100,813,000 114,252,000 169,626,000 100,143,000 68,075,000 42,495,000 93,467,000 108,929,000 94,812,000 76,398,000 119,525,000 104,018,000 102,553,000 106,202,000 100,708,000 113,131,000 118,296,000 96,625,000 96,596,000 80,994,000 266,974,000 53,614,000 62,430,000 39,534,000 39,992,000 33,680,000 29,821,000 37,278,000 24,941,000 15,587,000 24,508,000 19,318,000 13,370,000 8,621,000 6,494,000 4,988,000 12,339,000 10,392,000 21,572,000 93,339,000 104,144,000 
        short-term investments
      		172,436,000 187,947,000 175,466,000 173,973,000 184,444,000 149,289,000 162,330,000 193,589,000 230,365,000 201,964,000 191,928,000 208,995,000 241,371,000 233,170,000 257,600,000 288,637,000 309,211,000 313,343,000 315,834,000 300,265,000 310,755,000 307,772,000 307,441,000 127,966,000 110,096,000 111,553,000 113,385,000 110,402,000 111,575,000 110,667,000 100,555,000 95,207,000 98,177,000 94,506,000 89,494,000 90,420,000 90,590,000 89,268,000 88,615,000 81,588,000 77,848,000 69,552,000   
        accounts receivable
      		119,691,000 108,608,000 98,684,000 82,985,000 71,531,000 60,744,000 56,408,000 51,217,000 46,545,000 39,850,000 39,326,000 39,252,000 37,852,000 36,073,000 34,766,000 36,032,000 34,804,000 33,438,000 35,236,000 37,569,000 36,694,000 36,059,000 32,885,000 26,730,000 28,885,000 38,417,000 24,345,000 22,041,000 20,622,000 18,673,000 19,659,000 17,089,000 17,549,000  16,948,000 16,702,000 14,434,000  11,747,000 11,617,000 9,569,000 7,549,000 6,980,000 6,502,000 
        inventory
      		62,384,000 63,564,000 63,863,000 64,621,000 59,460,000 57,678,000 59,895,000 56,480,000 50,185,000 41,986,000 39,781,000 39,447,000 40,455,000 37,841,000 34,182,000 27,842,000 24,708,000 23,011,000 19,720,000 17,500,000 15,271,000 15,809,000 19,890,000 21,088,000 27,699,000 42,578,000 12,801,000 14,038,000 13,432,000 13,282,000 13,537,000 13,812,000 12,782,000  8,966,000 8,382,000 7,485,000  6,453,000 5,511,000 5,061,000 4,097,000 3,153,000 2,908,000 
        prepaid expenses and other current assets
      		26,993,000 24,052,000 18,509,000 13,673,000 14,857,000 12,455,000 18,506,000 14,420,000 19,020,000 18,194,000 19,565,000 18,754,000 19,804,000 17,250,000 18,275,000 16,033,000 16,278,000 15,626,000 17,887,000 16,905,000 14,954,000 13,206,000 13,235,000 10,464,000 11,092,000 7,900,000 19,223,000 14,728,000 4,428,000 4,124,000 4,218,000 4,336,000 3,278,000  2,495,000 2,340,000 2,579,000  2,708,000 1,430,000 1,653,000 1,290,000 1,281,000 701,000 
        total current assets
      		485,753,000 474,984,000 454,768,000 436,065,000 444,544,000 449,792,000 397,282,000 383,781,000 388,610,000 395,461,000 399,529,000 401,260,000 415,880,000 443,859,000 448,841,000 471,097,000 491,203,000 486,126,000 501,808,000 490,535,000 474,299,000 469,442,000 454,445,000 453,222,000 231,386,000 262,878,000 209,288,000 201,201,000 183,737,000 176,567,000 175,247,000 155,385,000 147,373,000  137,221,000 131,214,000 123,739,000  114,591,000 112,565,000 104,603,000 104,140,000 104,833,000 114,335,000 
        restricted cash
      		3,834,000 3,834,000 3,834,000 3,834,000 4,733,000 4,733,000 4,733,000 4,733,000 5,856,000 5,856,000 5,856,000 5,856,000 7,078,000 7,078,000 9,078,000 9,128,000 9,416,000 9,416,000 9,416,000 9,416,000 9,416,000 9,566,000 9,326,000 9,326,000 9,326,000 9,326,000 8,881,000 8,848,000 8,813,000 8,775,000       30,000  80,000 80,000 80,000 80,000 80,000 80,000 
        property and equipment
      		112,432,000 113,253,000 110,944,000 111,816,000 96,810,000 97,867,000 98,581,000 100,230,000 101,858,000 103,212,000 103,075,000 102,674,000 98,331,000 94,403,000 87,307,000 80,921,000 74,708,000 68,969,000 60,800,000 54,380,000 43,314,000 24,008,000 23,408,000 23,210,000 22,760,000 22,056,000 20,038,000 20,497,000 19,535,000 19,153,000 12,298,000 12,057,000 12,069,000  10,535,000 8,724,000 7,839,000  6,994,000 2,985,000 2,259,000 2,154,000 1,860,000 1,859,000 
        operating lease right-of-use asset
      		31,025,000 31,527,000 31,536,000 31,985,000  30,254,000    27,146,000    25,826,000    28,142,000 28,734,000 19,551,000 19,720,000 20,009,000 18,760,000 14,328,000 15,059,000 15,704,000 12,146,000 12,369,000 12,772,000                
        finance lease right-of-use asset
      		38,800,000 39,404,000 40,007,000 40,610,000 41,213,000 41,816,000 42,365,000 42,970,000 43,575,000 44,180,000 44,786,000 45,391,000 45,996,000 46,601,000 47,206,000 47,812,000 48,417,000 49,022,000 49,627,000 50,232,000 50,838,000 51,443,000 51,975,000 52,833,000 53,441,000 54,048,000 53,343,000 53,935,000                 
        intangible assets
      		133,028,000 141,916,000 264,136,000 270,491,000 257,869,000 263,445,000 269,418,000 275,673,000 281,919,000 282,956,000 289,184,000 295,412,000 301,640,000 307,869,000 314,097,000 320,325,000 326,553,000 332,781,000 339,009,000 345,237,000 351,465,000 357,693,000 363,921,000 370,149,000 376,377,000 382,605,000     393,000 1,311,000 2,229,000  4,088,000 5,029,000 5,970,000  7,479,000 8,392,000 9,305,000 10,218,000   
        goodwill
      		66,710,000 66,710,000 66,710,000 66,710,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000 66,134,000                   
        deposits and other assets
      		21,744,000 21,859,000 27,443,000 25,447,000 22,699,000 20,715,000 20,709,000 19,724,000 18,703,000 15,469,000 12,797,000 12,287,000 10,893,000 10,613,000 9,756,000 9,410,000 9,100,000 9,108,000 8,601,000 8,240,000 7,591,000 7,207,000 6,545,000 6,531,000 5,237,000 5,649,000 3,527,000 5,022,000 2,965,000 2,262,000 2,327,000 2,102,000 1,448,000  767,000 559,000 354,000  188,000 156,000 150,000 149,000 141,000 253,000 
        total assets
      		893,326,000 893,487,000 999,378,000 986,958,000 966,178,000 974,756,000 926,543,000 919,675,000 933,338,000 940,414,000 948,634,000 956,740,000 972,592,000 1,002,383,000 1,008,468,000 1,031,278,000 1,052,070,000 1,049,698,000 1,064,129,000 1,043,725,000 1,022,777,000 1,005,502,000 994,514,000 995,733,000 779,720,000 818,400,000 307,436,000 302,085,000 228,035,000 206,970,000 190,500,000 171,090,000 163,354,000 165,836,000 152,611,000 145,526,000 137,902,000 134,371,000 129,252,000 124,098,000 116,317,000 116,661,000 117,684,000 128,172,000 
        liabilities and stockholders' equity
      		                                            
        current liabilities:
      		                                            
        accounts payable
      		19,153,000 24,624,000 19,883,000 13,684,000 15,825,000 13,026,000 11,103,000 11,560,000 12,752,000 13,440,000 10,413,000 8,564,000 12,029,000 14,403,000 11,465,000 21,294,000 7,998,000 7,333,000 8,459,000 6,957,000 8,624,000 4,371,000 6,774,000 9,233,000 12,943,000 5,781,000 3,501,000 5,052,000 5,675,000 6,286,000 5,595,000 3,611,000 4,841,000  3,558,000 5,974,000 3,934,000  4,714,000 4,614,000 3,584,000 3,626,000 4,099,000 5,264,000 
        accrued liabilities
      		70,262,000 76,651,000 67,633,000 65,452,000 52,704,000 62,099,000 60,581,000 58,523,000 59,486,000 60,574,000 56,734,000 55,322,000 50,363,000 57,956,000 49,150,000 48,214,000 47,598,000 56,027,000 54,991,000 63,181,000 47,944,000 45,331,000 39,919,000 45,598,000 38,134,000 51,919,000 29,602,000 25,949,000 21,672,000 23,964,000 19,066,000 16,655,000 13,705,000  16,157,000 13,061,000 10,623,000  11,048,000 8,808,000 6,901,000 7,793,000 6,734,000 6,866,000 
        total current liabilities
      		89,415,000 101,275,000 87,516,000 79,136,000 68,529,000 75,125,000 71,684,000 70,083,000 72,238,000 74,014,000 67,147,000 63,886,000 62,392,000 72,359,000 60,615,000 69,508,000 55,596,000 63,360,000 63,450,000 349,477,000 335,564,000 49,702,000 46,693,000 54,831,000 51,077,000 57,700,000 33,103,000 31,001,000 27,347,000 30,365,000 24,771,000 20,371,000 18,646,000  19,807,000 19,124,000 14,642,000  18,841,000 18,729,000 17,989,000 20,362,000 19,677,000 21,460,000 
        operating lease liability
      		35,313,000 35,767,000 35,847,000 36,200,000 36,321,000 33,936,000 30,656,000 29,912,000 30,110,000 30,427,000 30,572,000 30,770,000 29,475,000 28,905,000 29,129,000 29,361,000 29,304,000 29,650,000 29,889,000 20,139,000 20,450,000 20,704,000 18,734,000 13,305,000 13,601,000 14,195,000 11,406,000 11,657,000 12,174,000                
        finance lease liability
      		67,743,000 68,109,000 68,468,000 68,823,000 69,159,000 69,463,000 69,712,000 70,009,000 70,289,000 70,538,000 70,784,000 71,023,000 72,023,000 72,172,000 72,319,000 72,464,000 72,594,000 72,699,000 72,803,000 72,905,000 61,068,000 60,690,000 60,702,000 60,435,000 59,316,000 58,435,000 68,851,000 68,209,000                 
        deferred tax liability
      		441,000 441,000 6,921,000 6,910,000 6,918,000 6,928,000 7,143,000 7,142,000 7,144,000 7,144,000 7,249,000 7,258,000 7,259,000 7,264,000 7,301,000 7,307,000 7,312,000 7,318,000 8,274,000 8,298,000 8,323,000 10,512,000 14,164,000 15,250,000 9,936,000 9,632,000                   
        other liabilities
      		29,486,000 31,740,000 31,083,000 30,777,000 21,292,000 22,373,000 22,080,000 20,678,000 19,710,000 13,752,000 12,793,000 12,905,000 11,186,000 10,278,000 9,494,000 9,448,000 9,330,000 9,494,000 8,981,000 8,581,000 7,598,000 7,029,000 5,982,000 5,489,000 4,491,000 5,166,000 3,960,000 3,413,000 3,025,000 2,745,000 2,322,000 2,186,000 1,680,000  703,000 468,000 307,000  208,000 231,000 269,000 238,000 95,000 10,000 
        total liabilities
      		222,398,000 237,332,000 229,835,000 221,846,000 202,219,000 207,825,000 258,034,000 254,516,000 482,608,000 478,648,000 470,975,000 467,929,000 464,078,000 472,378,000 459,914,000 468,801,000 454,506,000 462,547,000 463,080,000 459,400,000 433,003,000 338,053,000 332,951,000 333,309,000 138,421,000 145,128,000 117,320,000 114,280,000 42,546,000 33,110,000 27,093,000 22,557,000 20,326,000 27,634,000 20,510,000 19,592,000 14,949,000 17,097,000 19,049,000 18,960,000 18,258,000 21,470,000 22,914,000 33,381,000 
        commitments and contingencies
      		                                            
        stockholders' equity:
      		                                            
        preferred stock, 0.001 par value...
      		                                            
        common stock, 0.001 par value...
      		58,000 58,000 57,000 57,000 57,000 56,000 55,000 55,000 50,000 49,000 49,000 48,000 48,000 48,000 48,000 48,000 47,000 47,000 47,000 46,000 46,000 45,000 45,000 45,000 44,000 44,000 37,000 37,000 36,000 36,000 36,000 35,000 35,000  35,000 34,000 34,000  33,000 33,000 32,000 32,000 32,000 32,000 
        additional paid-in capital
      		1,621,272,000 1,586,056,000 1,566,029,000 1,545,557,000 1,525,014,000 1,509,831,000 1,377,825,000 1,353,495,000 1,089,280,000 1,059,751,000 1,039,266,000 1,021,126,000 1,008,955,000 997,470,000 985,407,000 971,646,000 960,870,000 952,432,000 943,486,000 933,328,000 920,819,000 976,590,000 959,186,000 943,706,000 883,136,000 861,740,000 414,665,000 399,452,000 390,887,000 378,352,000 369,709,000 348,611,000 339,314,000  325,701,000 320,500,000 313,916,000  302,678,000 298,678,000 293,841,000 291,853,000 289,098,000 287,074,000 
        accumulated other comprehensive income
      		2,643,000 3,303,000 3,062,000 2,872,000 2,605,000 2,615,000 2,620,000 2,191,000 1,437,000 1,165,000 764,000   -2,975,000 -3,823,000 -3,715,000 -3,387,000 15,000 987,000 652,000 1,128,000 1,004,000 1,874,000 2,467,000 2,019,000 1,330,000 1,837,000 1,233,000 1,174,000 738,000 707,000 311,000   -314,000 46,000 348,000  -151,000 -57,000 34,000 51,000 95,000 83,000 
        accumulated deficit
      		-952,913,000 -933,130,000 -799,473,000 -783,242,000 -763,585,000 -745,439,000 -711,859,000 -690,450,000 -639,905,000 -599,067,000 -562,288,000 -531,844,000 -499,032,000 -464,406,000 -432,946,000 -405,370,000 -359,834,000 -365,211,000 -343,339,000 -349,569,000 -332,087,000 -310,058,000 -299,410,000 -283,662,000 -243,768,000 -189,710,000 -226,291,000 -212,785,000 -206,476,000 -205,134,000 -206,913,000 -200,292,000 -194,894,000  -193,189,000 -194,514,000 -191,213,000  -192,225,000 -193,384,000 -195,716,000 -196,613,000 -194,323,000 -192,266,000 
        less treasury stock
      		-132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 -132,000  -132,000 -132,000 -132,000  -132,000 -132,000 -132,000 -132,000 -132,000 -132,000 
        total stockholders' equity
      		670,928,000  769,543,000 765,112,000 763,959,000  668,509,000 665,159,000 450,730,000  477,659,000 488,811,000 508,514,000  548,554,000 562,477,000 597,564,000  601,049,000 584,325,000 589,774,000  661,563,000 662,424,000 641,299,000  190,116,000 187,805,000 185,489,000  163,407,000 148,533,000 143,028,000  132,101,000 125,934,000 122,953,000  110,203,000 105,138,000 98,059,000  94,770,000  
        total liabilities and stockholders' equity
      		893,326,000 893,487,000 999,378,000 986,958,000 966,178,000 974,756,000 926,543,000 919,675,000 933,338,000 940,414,000 948,634,000 956,740,000 972,592,000 1,002,383,000 1,008,468,000 1,031,278,000 1,052,070,000 1,049,698,000 1,064,129,000 1,043,725,000 1,022,777,000 1,005,502,000 994,514,000 995,733,000 779,720,000 818,400,000 307,436,000 302,085,000 228,035,000 206,970,000 190,500,000 171,090,000 163,354,000  152,611,000 145,526,000 137,902,000  129,252,000 124,098,000 116,317,000    
        stockholders’ equity:
      		                                            
        total stockholders’ equity
      		 656,155,000    766,931,000    461,766,000    530,005,000    587,151,000    667,449,000    673,272,000    173,860,000    138,202,000    117,274,000    95,191,000   
        operating lease right-of-use assets
      		    32,176,000  27,321,000 26,430,000 26,683,000  27,273,000 27,726,000 26,640,000  26,049,000 26,451,000 26,539,000                            
        convertible senior notes
      		      56,759,000 56,692,000 283,117,000 282,773,000 282,430,000 282,087,000 281,743,000 281,400,000 281,056,000 280,713,000 280,370,000 280,026,000 279,683,000 279,339,000 278,996,000 189,416,000 186,676,000                      
        ​
      		                                            
        accumulated other comprehensive loss
      		           -387,000 -1,325,000                    -1,295,000            
        long-term debt
      		                       183,999,000                     
        deferred tax asset and receivable
      		                            213,000 213,000               
        deferred rent
      		                             115,000 110,000 105,000 100,000  92,000 89,000 85,000  40,000 21,000  12,000 24,000 36,000 
        income tax receivable
      		                          213,000 213,000                 
        deferred tax asset
      		                              235,000 235,000 235,000            
        balance sheet data:
      		                                            
        net working capital
      		                                 122,672,000    103,085,000       
        convertible preferred stock
      		                                            
        additional paid in capital
      		                                 331,073,000    308,815,000       
        noncontrolling interest
      		                                            
        total equity
      		                                 138,202,000    117,274,000    95,191,000 94,770,000  
        long-term debt, current portion
      		                                      3,039,000 5,286,000 7,504,000 8,931,000 8,820,000 9,294,000 
        long-term debt, less current portion
      		                                         765,000 3,039,000 11,638,000 
        stock warrant liability
      		                                         105,000 103,000 273,000 
        liabilities, convertible preferred stock and equity
      		                                            
        line of credit
      		                                            
        stockholders’ equity
      		                                            
        total liabilities, convertible preferred stock and equity
      		                                         116,661,000 117,684,000  
        intangible asset
      		                                          10,850,000 11,725,000 
        stockholders' equity
      		                                            
        liabilities, convertible preferred stock and (deficit) equity
      		                                            
        stockholders' (deficit) equity:
      		                                            
        total stockholders' (deficit) equity
      		                                           94,791,000 
        total (deficit) equity
      		                                           94,791,000 
        total liabilities, convertible preferred stock and (deficit) equity
      		                                           128,172,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 
                                                   
          operating activities
        		                                           
          net loss
        		-19,783,000 -133,657,000 -16,231,000 -19,657,000 -18,146,000 -33,580,000 -21,409,000 -50,545,000 -40,838,000 -36,779,000 -30,444,000   -31,460,000 -27,576,000    6,230,000 -17,482,000 -16,469,000  -15,748,000 -39,894,000 -54,058,000  -13,506,000 -6,309,000 -1,342,000  -6,621,000           -2,290,000  
          adjustments to reconcile net loss to net cash from operating activities:
        		                                           
          depreciation
        		2,909,000 2,812,000 2,777,000 2,725,000 2,651,000 2,768,000 2,743,000 2,753,000 2,685,000 2,287,000 2,226,000 2,151,000 2,078,000 1,954,000 1,666,000 1,662,000 1,382,000  1,162,000 1,163,000 1,150,000                       
          amortization of intangible assets
        		8,888,000 9,352,000 6,356,000 5,844,000 5,576,000 5,972,000 6,256,000 6,245,000 6,228,000 6,228,000 6,228,000 6,228,000 6,228,000 6,228,000 6,228,000 6,228,000 6,228,000  6,228,000 6,228,000 6,228,000                       
          amortization of right-of-use lease assets
        		1,085,000 1,064,000 1,055,000 1,055,000 1,078,000                                       
          deferred income tax benefit
        		 -6,480,000 11,000 -8,000 -10,000 -215,000 1,000   -105,000 -9,000 -1,000 -5,000 -37,000 -5,000 -6,000 -6,000 -957,000 -24,000 -24,000 -24,000 -2,836,000 -1,086,000 -7,545,000 -709,000                   
          loss on disposal of fixed assets
        		103,000 1,000 20,000 5,000 6,000 534,000 0           10,000    80,000 272,000   404,000 19,000   73,000 5,000 77,000 1,000 1,000 0         
          stock-based compensation
        		19,144,000 17,300,000 14,913,000 18,019,000 12,986,000 13,309,000 14,420,000 11,313,000 11,165,000 12,987,000 10,484,000 9,873,000 10,184,000 11,688,000 9,411,000 10,539,000 6,923,000 7,225,000 6,189,000 7,984,000 8,748,000 8,744,000 9,660,000 10,897,000 17,176,000 12,470,000 8,547,000 8,247,000 7,129,000 6,668,000 7,173,000 6,461,000 5,402,000 4,939,000 4,718,000 4,733,000 3,202,000 2,669,000 2,652,000 2,048,000 1,417,000 1,558,000 1,552,000 
          unrealized foreign currency loss
        		574,000                                           
          amortization of premium on short-term investments
        		-187,000  -498,000 -1,050,000 -1,149,000  -962,000 -1,114,000 -1,111,000  -699,000 -287,000 -55,000 130,000 159,000 206,000 236,000                -58,000 -35,000 -3,000 31,000 27,000 4,000 45,000 79,000 82,000   
          other liabilities
        		-2,249,000 654,000 313,000 1,906,000 -1,091,000 312,000 1,398,000 970,000 2,526,000 818,000 -122,000 1,669,000 684,000   118,000 -163,000 514,000 400,000 981,000 570,000  1,019,000 2,117,000 207,000                   
          allowance for doubtful accounts
        		823,000 310,000 3,002,000 2,700,000 1,367,000                                       
          changes in operating assets and liabilities:
        		                                           
          accounts receivable
        		-12,459,000 -10,244,000 -18,792,000 -11,668,000 -12,316,000 -5,490,000 -4,462,000 -4,908,000 -7,106,000 -308,000 -435,000 -1,449,000 -1,651,000 -17,000 175,000 -1,873,000 -1,423,000 1,206,000 2,173,000 -1,132,000 -547,000 -3,386,000 -5,927,000 2,310,000 9,246,000 -804,000 -2,475,000 -1,394,000 -1,959,000 957,000 -2,565,000 219,000 -863,000 302,000 -194,000 -2,208,000 -81,000 -2,621,000 -119,000 -2,069,000 -1,982,000 -575,000 -476,000 
          inventory
        		832,000 -3,962,000 659,000 -2,731,000 -1,668,000 -627,000 -3,056,000 -6,554,000 -8,551,000 -1,927,000 -620,000 806,000 -3,089,000 -3,591,000 -6,730,000 -3,401,000 -1,750,000 -3,446,000 -2,394,000 -2,266,000 403,000 -20,616,000 1,182,000 6,828,000 14,568,000 3,664,000 1,166,000 -595,000 -157,000 208,000 215,000 -1,236,000 -1,490,000 -2,244,000 -550,000 -830,000 -538,000 -744,000 -612,000 -450,000 -1,129,000 -948,000 -243,000 
          prepaid expenses and other current assets
        		-2,985,000 -5,525,000 -4,852,000 1,420,000 -2,339,000 3,652,000 -3,971,000 4,565,000 -912,000 1,470,000 -887,000 1,030,000 -2,498,000 1,635,000 -2,753,000 67,000 -669,000 1,985,000 -1,281,000 -1,955,000 -1,803,000 -704,000 -2,723,000 629,000 -2,235,000 1,409,000 -2,788,000 635,000 -173,000 -61,000 106,000 -1,093,000 -708,000 -74,000 -153,000 243,000 478,000 -366,000 -1,265,000 224,000 -355,000 -7,000 -581,000 
          accounts payable and accrued liabilities
        		-10,192,000 11,138,000 7,799,000 6,616,000 -6,729,000 4,427,000 565,000 -1,351,000 -3,620,000 7,454,000 3,376,000 -259,000 -9,266,000 9,057,000 -10,214,000 15,945,000 -7,578,000 782,000 -3,658,000 12,301,000 3,023,000 3,458,000 -8,139,000 6,748,000 -4,750,000 839,000 1,951,000 3,123,000 -5,134,000 4,527,000 4,149,000 1,907,000 -8,056,000 6,967,000 629,000 4,461,000 -2,316,000 2,100,000 968,000 2,844,000 -816,000 356,000 -25,000 
          deposits and other assets
        		971,000 6,462,000 -472,000 -683,000 -134,000                                       
          net cash from operating activities
        		-12,526,000 6,843,000 -10,090,000 6,979,000 -18,521,000 507,000 -9,586,000 -18,369,000 -33,870,000 -10,665,000 -8,168,000 -8,161,000 -30,764,000 -4,136,000 -26,515,000 -12,206,000 9,774,000 -4,651,000 17,790,000 7,391,000 4,178,000 10,604,000 -9,570,000 -10,923,000 -13,099,000 -4,191,000 -2,988,000 6,602,000 208,000 17,128,000 4,362,000 4,012,000 -6,638,000 11,879,000 6,991,000 4,262,000 2,376,000 3,278,000 3,929,000 6,039,000 -937,000 -570,000 -557,000 
          capital expenditures
        		-3,096,000 -832,000 -1,387,000 -1,091,000 -1,436,000 -938,000 -1,848,000 -3,212,000 607,000 -6,082,000 -3,239,000 -5,107,000 -4,487,000 -7,682,000 -6,091,000 -8,796,000 -3,899,000 -9,327,000 -9,916,000 -11,360,000 -17,182,000 -2,145,000 -1,281,000 -2,727,000 -782,000 -1,194,000 -1,007,000 -1,872,000 -651,000 -7,582,000 -727,000 -760,000 -1,246,000 -1,858,000 -2,382,000 -1,311,000 -760,000 -2,042,000 -3,017,000 -842,000 -377,000 -375,000 -183,000 
          free cash flows
        		-15,622,000 6,011,000 -11,477,000 5,888,000 -19,957,000 -431,000 -11,434,000 -21,581,000 -33,263,000 -16,747,000 -11,407,000 -13,268,000 -35,251,000 -11,818,000 -32,606,000 -21,002,000 5,875,000 -13,978,000 7,874,000 -3,969,000 -13,004,000 8,459,000 -10,851,000 -13,650,000 -13,881,000 -5,385,000 -3,995,000 4,730,000 -443,000 9,546,000 3,635,000 3,252,000 -7,884,000 10,021,000 4,609,000 2,951,000 1,616,000 1,236,000 912,000 5,197,000 -1,314,000 -945,000 -740,000 
          investing activities
        		                                           
          purchases of short-term investments
        		-31,353,000 -40,160,000 -75,366,000 -42,022,000 -74,743,000 -66,864,000 -32,002,000 -41,839,000 -49,250,000 -72,049,000 -23,468,000 -73,775,000 -96,295,000 -12,000,000 -10,318,000 -20,191,000 -16,747,000 -23,529,000 -94,523,000 -43,226,000 -54,007,000 -27,204,000 -212,915,000 -42,203,000 -18,680,000 -15,662,000 -23,868,000 -24,245,000 -16,613,000 -23,596,000 -22,968,000 -19,213,000 -27,919,000 -22,870,000 -25,671,000 -19,167,000 -26,599,000 -14,468,000 -24,899,000 -12,115,000 -23,710,000   
          proceeds from sales and maturities of short-term investments
        		46,575,000 27,984,000 74,543,000 53,533,000 40,878,000 80,308,000 65,161,000 79,850,000 21,880,000 64,365,000 41,822,000 107,011,000 89,902,000 37,663,000 40,746,000 39,564,000 17,184,000 24,560,000 78,664,000 53,343,000 50,349,000 26,613,000 33,073,000 25,335,000 19,676,000 18,624,000 20,801,000 24,880,000 16,189,000 14,666,000 17,763,000 22,325,000 24,097,000 17,701,000 26,610,000 19,323,000 25,257,000 13,652,000 17,748,000 8,354,000 15,600,000   
          purchases of property and equipment
        		-3,959,000 -2,914,000 -1,635,000 -1,179,000 -1,938,000 -1,733,000 -1,450,000 -2,149,000 -968,000 -4,214,000 -3,360,000 -5,766,000 -6,908,000 -8,221,000 -6,039,000 -9,401,000 -6,604,000 -9,327,000 -9,916,000 -11,360,000 -17,182,000 -2,145,000 -1,281,000 -2,727,000 -782,000 -1,194,000 -1,007,000 -1,872,000 -651,000 -7,582,000 -727,000 -760,000 -1,246,000 -1,858,000 -2,382,000 -1,311,000 -760,000 -2,042,000 -3,017,000 -842,000 -377,000 -375,000 -183,000 
          investment in company-owned life insurance
        		-759,000 -800,000 -1,535,000 -2,070,000 -395,000 76,000 -1,146,000 -1,036,000 -1,045,000 -1,023,000 -97,000 -1,519,000 -531,000 -842,000 2,000 -383,000 215,000 -576,000 -288,000 -794,000 -423,000 -723,000 -439,000 -1,072,000 414,000    -638,000               
          other investing activities
        		 0 0 0 -750,000                                       
          net cash from investing activities
        		10,504,000 -15,890,000 -3,993,000 -20,782,000 -36,948,000 11,787,000 30,563,000 34,864,000 -29,383,000 -12,921,000 14,897,000 25,951,000 -13,832,000 16,655,000 24,391,000 9,630,000 -5,897,000 -8,872,000 -26,063,000 -2,034,000 -21,263,000  -181,562,000 -20,667,000 628,000  -4,074,000 -599,000 -1,713,000 -17,752,000 -5,932,000 2,352,000 -5,068,000 -7,027,000 -1,443,000 -1,155,000 -2,102,000 -2,858,000 -10,168,000 -4,603,000 -8,487,000 -70,126,000 -183,000 
          financing activities
        		                                           
          proceeds from exercise of stock options
        		19,330,000 2,916,000 1,483,000 4,972,000 4,082,000 9,838,000 5,509,000 10,945,000 13,055,000 6,124,000 4,310,000 1,639,000 675,000 706,000 950,000 1,373,000 548,000 1,741,000 1,559,000 6,272,000 16,552,000 9,938,000 3,668,000 2,136,000 4,454,000 1,059,000 4,834,000 4,564,000 4,607,000 2,236,000 11,812,000 3,154,000 1,452,000 433,000 484,000 812,000 1,970,000 2,310,000 1,335,000 1,976,000 438,000 15,000 355,000 
          proceeds from share purchases under employee stock purchase plan
        		2,381,000  4,725,000 0 2,961,000  4,729,000 0 2,687,000  4,115,000 0 2,163,000  3,845,000 0 1,785,000  3,268,000 0 1,549,000  2,747,000 0 1,278,000  2,486,000                 
          payment of employee taxes related to vested restricted stock units
        		-5,638,000  -649,000 -2,449,000 -4,845,000  -328,000 -2,127,000 -2,378,000  -768,000 -2,341,000 -1,537,000  -445,000 -1,136,000 -818,000  -858,000 -1,747,000 -1,065,000  -594,000 -501,000 -1,512,000  -654,000 -4,246,000 -102,000  -7,000             
          principal paid on finance lease
        		-304,000 -300,000 -295,000 -278,000 -248,000 -212,000 -242,000 -226,000 -197,000 -194,000 -190,000 -178,000 -149,000 -147,000 -144,000 -131,000 -105,000 -104,000 -102,000 -202,000 -251,000                       
          net cash from financing activities
        		15,769,000 2,427,000 5,264,000 2,245,000 1,950,000 60,113,000 9,668,000 8,592,000 13,167,000 7,303,000 7,467,000 -880,000 1,152,000 529,000 4,206,000 106,000 1,410,000 1,617,000 3,867,000 16,362,000 17,414,000 8,659,000 5,821,000 243,842,000 4,220,000 -22,036,000 6,666,000 318,000 5,407,000 1,974,000 13,926,000 2,836,000 2,840,000 433,000 484,000 1,780,000 1,970,000 422,000 -911,000 550,000 -1,703,000 -988,000 -10,075,000 
          effect of exchange rate changes on cash and cash equivalents
        		-311,000 -813,000 6,252,000 -2,780,000 -1,855,000 -2,924,000 1,423,000 -630,000 -886,000 821,000 -79,000 282,000 317,000 459,000 -667,000 -1,467,000 207,000 -517,000 -759,000 -48,000 -450,000 38,000 -669,000 1,108,000 -565,000 -244,000 -29,000   -32,000 -19,000 154,000 -55,000 -95,000 -84,000 -138,000 -117,000 664,000 -201,000 -39,000 -53,000 -83,000 10,000 
          net increase in cash, cash equivalents and restricted cash
        		13,436,000 -7,433,000    69,483,000    -15,462,000 14,117,000 17,192,000 -43,127,000 13,507,000 1,415,000 -3,937,000 5,494,000 -12,423,000    15,842,000 -185,980,000 213,360,000 -8,816,000 23,341,000 -425,000 6,347,000 3,897,000 1,318,000 12,337,000 9,354,000 -8,921,000           
          cash, cash equivalents and restricted cash at beginning of period
        		94,647,000 0 0 0 174,359,000 0 0 0 99,323,000 0 0 0 126,603,000 0 0 0 110,124,000 0 0 0 106,162,000 0 0 0 71,756,000 0 0 0 38,596,000 0 0 0 24,508,000           
          cash, cash equivalents and restricted cash at end of period
        		108,083,000 -7,433,000 -2,567,000 -14,338,000 118,985,000 69,483,000 32,068,000 24,457,000 48,351,000 -15,462,000 14,117,000 17,192,000 83,476,000 13,507,000 1,415,000 -3,937,000 115,618,000 -12,423,000 -5,165,000 21,671,000 106,041,000 15,842,000 -185,980,000 213,360,000 62,940,000 23,341,000 -425,000 6,347,000 42,493,000 1,318,000 12,337,000 9,354,000 15,587,000           
          supplemental disclosures of cash flow information
        		                                           
          taxes paid, net of refunds
        		379,000 265,000 173,000 235,000 276,000 195,000 364,000 450,000 351,000 339,000 438,000 525,000 255,000                               
          other interest paid
        		1,042,000 1,048,000 1,049,000 1,057,000 1,058,000 1,073,000 1,077,000 1,243,000 1,073,000 1,111,000 1,076,000   1,084,000 1,159,000 1,100,000 1,091,000                           
          supplemental schedule of noncash investing and financing activities
        		                                           
          purchases of property and equipment included in accounts payable and accrued liabilities
        		863,000 2,082,000 248,000 88,000 502,000 795,000 -398,000 -1,063,000 1,575,000 -1,868,000 121,000 659,000 2,421,000 539,000 -52,000 605,000 2,705,000                           
          impairment of intangible asset
        		                                           
          amortization of debt issuance costs
        		     56,000 67,000 252,000 343,000 343,000 343,000 344,000 343,000 343,000 343,000 344,000 343,000 343,000 343,000 344,000 343,000                       
          unrealized foreign currency losses
        		   2,486,000 1,397,000 4,130,000 -2,421,000 1,455,000 1,456,000 -1,971,000 894,000 283,000 -186,000 -1,977,000 1,950,000 2,404,000 -135,000 477,000 1,009,000 -274,000 1,101,000 -1,224,000   2,024,000 -275,000 673,000 -291,000 87,000 106,000 356,000             
          amortization of premium accretion of discount on short-term investments
        		                                           
          acquired in-process r&d acquired through the issuance of common stock
        		     0 0 0 5,000,000 0 0                                 
          loss on capped call transaction
        		                                           
          inducement expense related to exchange of convertible senior notes
        		     0 0                                     
          inventory write-down
        		                                           
          provision for excess and obsolete inventory
        		                                           
          cash paid for acquisitions, net of cash acquired
        		 0 0                                         
          purchase of certain real property
        		                                           
          proceeds from disposal of property and equipment
        		     0 0       55,000 0 41,000 55,000 0 0                         
          proceeds from partial unwinding of capped calls related to issuance of convertible senior notes
        		                                           
          share purchases under employee stock purchase plan
        		                            902,000 0 2,121,000 0 1,388,000 0 0   1,152,000 0     
          payments of employee taxes related to vested restricted stock units
        		                                           
          payments related to convertible senior notes
        		                                           
          payments related to capped call transactions
        		                                           
          contingent consideration acquired
        		 0 0                                         
          convertible senior notes exchanged for common stock, net of debt issuance costs
        		     0                                      
          issuance of common stock related to conversion of convertible senior notes, net of debt issuance costs
        		                                           
          interest paid on convertible senior notes
        		     791,000 0   3,953,000 0   3,953,000                              
          purchase of real estate property
        		  0                                         
          net decrease in cash, cash equivalents and restricted cash
        		   -14,338,000 -55,374,000   24,457,000 -50,972,000           21,671,000 -121,000                       
          (amortization of premium) accretion of discount on short-term investments
        		                                           
          other assets
        		     -67,000 183,000 25,000 -2,216,000 -1,636,000 -421,000 118,000 59,000 187,000 -360,000 62,000 -217,000 84,000 -73,000 146,000 29,000 69,000 429,000 -212,000 1,000 -1,691,000 -29,000 5,000 -62,000 1,332,000 -229,000 -739,000 -160,000 -431,000 -209,000 -205,000 -163,000 101,000    -7,000 -10,000 
          noncash lease expense
        		      1,062,000 1,061,000 1,071,000  1,037,000                                 
          convertible notes exchanged for common stock, net of debt issuance costs
        		                                           
          gain on disposal of fixed assets
        		        10,000      64,000 10,000 -45,000                           
          adjustments to reconcile net loss to net cash (used in) provided operating activities:
        		                                           
          (accretion of discount) amortization of premium on short-term investments
        		                                           
          proceeds from tenant improvement allowance
        		                 0 0 12,039,000 629,000                       
          net income
        		            -34,626,000    5,377,000                -2,711,000 1,006,000 1,325,000 -3,301,000 878,000 134,000 1,159,000 2,332,000 897,000   
          adjustments to reconcile net income to net cash from operating activities:
        		                                           
          amortization of lease right-of-use assets
        		            1,036,000  1,082,000 1,025,000 1,271,000  1,232,000 1,117,000 1,170,000  1,259,000 1,266,000 1,311,000  1,009,000                 
          interest paid
        		            1,086,000                         32,000 56,000 85,000 112,000 140,000 195,000 
          amortization of the fair market value inventory adjustment
        		                                           
          amortization of debt discount
        		                                           
          change in fair value of cash-settled stock options
        		                                           
          proceeds from convertible senior notes
        		                     0 0                     
          payment of convertible senior notes transaction costs
        		                     0 0                     
          purchase of capped calls related to issuance of convertible senior notes
        		                     0 0                     
          taxes paid
        		              132,000 149,000 91,000  87,000    124,000 44,000 250,000  5,000 51,000 40,000  -352,000 362,000 3,000  0 63,000 1,000  1,000 1,000 62,000 11,000 3,000 
          ​
        		                                           
          depreciation and amortization
        		                     7,400,000 7,337,000 7,334,000 7,310,000 3,632,000 946,000 886,000 842,000 1,201,000 1,702,000 1,696,000 1,665,000 1,541,000 1,513,000 1,419,000 1,009,000 1,312,000 1,155,000 1,133,000 1,122,000 1,068,000 1,056,000 
          amortization of the fair market value inventory adjustment as a result of the avedro merger
        		                                           
          amortization of premium (discount) on short-term investments
        		                   260,000 256,000                       
          cash acquired due to acquisition
        		                                           
          payment of debt assumed in the avedro merger
        		                                           
          shares issued, and replacement awards assumed, in connection with avedro merger
        		                                           
          debt assumed in the avedro merger
        		                                           
          change in fair value of cash settled stock options
        		                      0 -1,000 -3,171,000                   
          taxes (refunded) paid
        		                    -35,000                       
          amortization of debt discount and deferred financing costs
        		                                         0 0 
          deferred rent and other liabilities
        		                         1,686,000 1,576,000 1,401,000 689,000 428,000              
          net cash (used) provided by investing activities
        		                                           
          amortization of debt discount and issuance costs
        		                      2,677,000                     
          amortization of discount on short-term investments
        		                      196,000 52,000 -19,000  -77,000 -109,000 -112,000               
          fair value of cash-settled stock options
        		                                           
          amortization of (discount) premium on short-term investments
        		                             -90,000 -70,000             
          deferred tax asset and receivable
        		                                           
          net cash from (used) in investing activities
        		                                           
          reduction of liability upon vesting of stock options previously exercised for unvested stock
        		                                 0 1,000 0 3,000 8,000 12,000 21,000 21,000 21,000 21,000 
          amortization of operating lease right-of-use asset
        		                            400,000               
          change in fair value of stock warrant liability
        		                                     0 0 0 -43,000 2,000 -31,000 
          payments of subordinated notes
        		                                         -2,164,000 -2,137,000 
          proceeds from exercise of stock warrants
        		                                     0 0   0 50,000 
          restricted cash
        		                                 0 0 31,000 49,000       
          deferred rent
        		                               511,000 839,000 145,000 239,000 165,000 173,000   -17,000 19,000 30,000 72,000 
          unrealized foreign currency gains
        		                                -499,000  -324,000 -282,000 -342,000       
          adjustments to reconcile net income to net cash from (used) in operating activities:
        		                                           
          loss on deconsolidation of dose
        		                                         0 0 
          loss on extinguishment of debt
        		                                         0  
          deferred tax asset
        		                                           
          purchase of idose product line and related assets from dose medical
        		                                         0 0 
          proceeds from public offering, net of issuance costs
        		                                           
          proceeds from senior secured term and draw-to term loans
        		                                         0  
          payments of senior secured term and draw-to term loans
        		                                         0  
          proceeds from line of credit
        		                                           
          payments of line of credit
        		                                           
          net increase in cash and cash equivalents
        		                                 5,190,000 5,948,000 4,749,000 2,127,000 1,506,000 -7,351,000 1,947,000 -11,180,000 -71,767,000 -10,805,000 
          cash and cash equivalents at beginning of period
        		                                 0 0 0 6,494,000 0 0 0 21,572,000 0 0 
          cash and cash equivalents at end of period
        		                                 5,190,000 5,948,000 4,749,000 8,621,000 1,506,000 -7,351,000 1,947,000 10,392,000 -71,767,000 -10,805,000 
          purchase of intangible assets in exchange for future payments
        		                                           
          conversion of preferred stock into common stock
        		                                           
          payments of secured notes
        		                                      -2,246,000 -2,219,000 -2,191,000   
          unrealized gains on intercompany loans
        		                                       -80,000 -149,000   
          proceeds from exercise of stock warrant
        		                                        50,000   
          unrealized losses on intercompany loans
        		                                           
          accrued interest expense
        		                                           
          proceeds from issuance of series f preferred stock
        		                                           
          payment to acquire treasury stock
        		                                           
          purchase of intangible asset in exchange for issuance of subordinated note
        		                                           
          conversion of convertible notes and accrued interest into series f convertible preferred stock
        		                                           
          proceeds from initial public offering, net of issuance costs
        		                                          -1,343,000 
          net payments of revolving line of credit
        		                                          0 
          net proceeds from senior secured term and draw-to term loans
        		                                           
          issuance costs associated with initial public offering in accounts payable and accrued liabilities